Please do not adjust margins
ChemComm
Page 4 of 4
DOI: 10.1039/C6CC05138C
COMMUNICATION
Journal Name
Diomedi, R. Giovannini, M. Mari, L. Marsili and E.
Marcantoni, Eur. J. Org. Chem. 2012, 630.
In conclusion, we have developed a metal‐free approach
for the synthesis of 5‐methyl‐arylsulfonyloxazoles by iodine‐
promoted sulfonylation of N‐propynyl amides with sulfonyl
hydrazides followed by DBU‐mediated cyclization. Similarly,
the oxysulfenylation of N‐allyl amides, which proceeded via
the electrophilic addition of in situ generated sulfenyl iodide,
produced 5‐methyl‐arylthiooxazolines. The key features of
these reactions are broad functional group tolerance, mild
conditions, the formation of two new bonds (C‐S and C‐O) and
applicability to alkyl sulfonyl hydrazides as well as to internal
alkynes.
8
9
A. Arcadi, S. Cacchi, L. Cascia, G. Fabrizi, F. Marinelli, Org.
Lett., 2001, 3, 2501.
A. S. K. Hashmi, M. C. B. Jaimes, A. M. Schuster, and F.
Rominger, J. Org. Chem., 2012, 77, 6394.
10 H. Peng, N. G. Akhmedov, Y. ‐F. Liang, N. Jiao, and X. Shi, J.
Am. Chem. Soc., 2015, 137, 8912.
11 B. Wang, Y. Chen, L. Zhou, J. Wang, C. ‐H. Tung, Z. Xu, J. Org.
Chem., 2015, 80, 12718.
12 (a) N. G. Moon and A. M. Harned, Tetrahedron Lett., 2013,
54, 2960; (b) G. ‐Q. Liu, C. ‐H. Yang, Y. ‐M. Li, J. Org. Chem.,
2015, 80, 11339; (c) A. Alhalib, S. Kamouka, and W. J. Moran,
Org. Lett., 2015, 17, 1453; (d) L. Engman, J. Org. Chem.,
1991, 56, 3425; (e) S. Minakata, Y. Morino, Y. Oderaotoshi,
The authors gratefully acknowledge funding from the
ministry of science and technology (MOST), Taiwan, and the
Centre for Research and Development of Kaohsiung Medical
University for 400 MHz NMR analyses, LC‐MS and GC‐MS
analysis.
and M. Komatsu, Org. Lett., 2006, 8, 3335; (f) Z. K. M. A. E.
Samii, M. I. A. Ashmawy and J. M. Mellor, Tetrahedron Lett.,
1987, 28, 1949; (g) J. Yu, H. Tian, C. Gao, H. Yang, Y. Jiang, H.
Fu, Synlett, 2015, 26, 676.
13 For selected examples on sulfonyl insertion from
sulfonylhydrazides, see: (a) (a) L. Zhang, S. Chen, Y. Gao, P.
Zhang, Y. Wu, G. Tang, and Y. Zhao, Org. Lett., 2016, 18
,
1286; (b) W. –J. Hao, Y. Du, D. Wang, B. Jiang, Q. Gao, S. –J.
Tu and G. Li, Org. Lett., 2016, 18, 1884; (c) R. Singh, B. K.
Allam, N. Singh, K. Kumari, S. K. Singh, and K. N. Singh, Org.
Lett. 2015, 17, 2656; (d) J. Zhang, Y. Shao, H. Wang, Q. Luo, J.
Chen, D. Xu, and X. Wan, Org. Lett., 2014, 16, 3312; (e) X. Li,
X. Xu and X. Shi, Tetrahedron Lett., 2013, 54, 3071; (f) W.
Wei, C. Liu, D. Yang, J. Wen, J. You, Y. Suo and H. Wang,
Chem. Commun., 2013, 49, 10239.
Notes and references
1
(a) S. Y. Woo, J. H. Kim, M. K. Moon, S. ‐H. Han, S. K. Yeon, J.
W. Choi, B. K. Jang, H. J. Song, Y. G. Kang, J. W. Kim, J. Lee, D.
J. Kim, O. Hwang and K. D. Park, J. Med. Chem., 2014, 57
,
1473; (b) A. Cohen, M. D. Crozet, P. Rathelot, N. Azas and P.
Vanelle, Molecules, 2013, 18, 97; (c) K. A. M. Walker, D. J.
Kertesz, D. M. Rotstein, D. C. Swinney, P. W. Berry, O. ‐Y. So,
A. ‐S. Webb, D. M. Watson, A. Y. Mak, P. M. Burton, B. Mills‐
Dunlap, M. Y. Chiou, L. G. Tokes, L. J. Kurz, J. R. Kern, K. W.
14 For recent examples of sulfenylation, see: (a) Y. Yang, S.
Zhang, L. Tang, Y. Hu, Z. Zha and Z. Wang, Green Chem.,
2016, 18, 2609; (b) X. Zhao, T. Li, L. Zhang and K. Lu, Org.
Biomol. Chem., 2016, 14, 1131; (c) X. Li, Y. Xu, W. Wu, C.
Jiang, C. Qi and H. Jiang, Chem. Eur. J., 2014, 20, 7911; (d) G.
Chan, A. Salari and G. R. Mendizabal, J. Med. Chem., 1993,36
,
2236; (d) I. A. Leneva, R. J. Russell, Y. S. Boriskin and A. J.
Hay, Antiviral Res., 2009, 81, 132.
Kumaraswamy, and R. Raju, Adv. Synth. Catal., 2014, 356
,
2
For reviews on oxazoles and oxazolines, see: (a) I. J. Turchi
and M. J. S. Dewar, Chem. Rev., 1975, 75, 389; (b) H. H.
Wasserman, K. E. McCarthy and K. S. Prowse, Chem. Rev.,
1986, 86, 845; (c) I. J. Turchi, Ind. Eng. Chem. Prod. Res. Dev.,
1981, 20, 32; (d) J. A. Frump, Chem. Rev., 1971, 71, 483; (e)
A. I. Meyers and E. D. Mihelich, Angew. Chem. Int. Ed., 1976,
15, 250; (f) G. Desimoni and G. F. P. Quadrelli, Chem. Rev.,
2003, 103, 3119.
2591; (e) F. ‐L. Yang, F. ‐X. Wang, T. ‐T. Wang, Y. ‐J. Wang and
S. ‐K. Tian, Chem. Commun., 2014, 50, 2111; (f) F. ‐L. Yang
and S. ‐K. Tian, Angew. Chem. Int. Ed., 2013, 52, 4929.
15 (a) G. C. Senadi, B. S. Gore, W. P. Hu, and J. J. Wang, Org.
Lett., 2016, 18, 2890; (b) J. K. Vandavasi, W. P. Hu, G. C.
Senadi, H. T. Chen, H. Y. Chen, K. C. Hsieh and J. J. Wang,
Adv. Synth. Catal., 2015, 357, 2788; (c) G. C. Senadi, W. P.
Hu, T. Y. Lu, A. M. Garkhedkar, J. K. Vandavasi and J. J. Wang,
Org. Lett., 2015, 17, 1521; (d) S. S. K. Boominathan, W. P. Hu,
G. C. Senadi, J. K. Vandavasi, J. J. Wang, Chem. Commun.,
2014, 51, 6726; (e) W. C. Lee, H. C. Shen, W. P. Hu, W. S. Lo,
C. Murali, J. K. Vandavasi and J. J. Wang, Adv. Synth. Catal.,
2012, 354, 2218.
3
4
5
(a) WIPO., WO2010142934A1, 2010; (b) US pat.,
US6767426B1, 2004; (c) E. R. Freiter, A. H. Abdallah and S. J.
Strycker, J. Med. Chem., 1973, 16, 510.
For recent review on N‐propynylamides, see: (a) Y. Hu, X. Xin,
B. Wan, Tetrahedron Lett, 2015, 56, 32 and references cited
therein.
For selected examples on synthesis of oxazoles and
oxazolines from N‐propynylamides, see: (a) G. C. Senadi, W. ‐
P. Hu, J. ‐S. Hsiao, J. K. Vandavasi, C. ‐Y. Chen, and J. ‐J. Wang,
Org. Lett., 2012, 14, 4478 and references cited therein; (b) J.
P. Weyrauch, A. S. K.Hashmi, A. M. Schuster, T. Hengst, S.
Schetter, A. Littmann, M. Rudolph, M. Hamzic, J. Visus, F.
Rominger, W. Frey, J. W. Bats, Chem.—Eur. J., 2010, 16, 956;
(c) V. H. L. Wong, A. J. P. White, T. S. Hor and K. K. Hii, Adv.
Synth. Catal., 2015, 357, 3943 and references cited therein;
(d) Y. Wang, M. Jiang and J. ‐T. Liu, Org. Chem. Front., 2015,
16 The CCDC number for the compounds 4aa (1465160), 4ab
(1465161), 4ac (1465166), 4ad (1465163), 4af (1465164),
4ag (1465165), 4ma (1465167), 4oa (1465162), and 3ja’
(1473425).
17 When N‐allylbenzamide 5a and tosylhydrazides 2a was
treated with I2/TBHP, the desired oxazoline was not isolated
instead N‐(2‐hydroxy‐3‐tosylpropyl)benzamide 6aa’ was
isolated in less than 10% along with other unidentified
compounds.
18 For complete optimization of reaction condition (see the
ESI†).
2
, 542. (d) A. Alhalib and W. J. Moran, Org. Biomol. Chem.,
19 (a) The sulfonyl radical does not form via the intermediate S‐
p‐tolyl‐4‐methylbenzenesulfonothioate 2a' as proposed in
2014, 12, 795.
6
7
(a) X. Meng and S. Kim, Org. Biomol. Chem., 2011, 9, 4429;
(b) A. S. K. Hashmi, A. M. Schuster, M. Schmuck, and F.
Rominger, Eur. J. Org. Chem., 2011, 4595.
ref 13c; (b) Intermediate
H was proposed based on the
acidity of the methylene proton and result obtained from
Scheme 2.
(a) P. Wipf, Y. Aoyama, and T. E. Benedum, Org. Lett., 2004,
6
, 3593; (b) E. Merkul and T. J. J. Muller, Chem. Commun.,
2006, 4817; (c) G. Bartoli, C. Cimarelli, R. Cipolletti, S.
4 | J. Name., 2012, 00, 1‐3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins